SIMILAR PATTERNS OF AMINO ACIDS FOR 3P97_C_SAMC263_0
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1e08 | [FE]-HYDROGENASE(LARGE SUBUNIT) (Desulfovibriodesulfuricans) |
PF02906(Fe_hyd_lg_C)PF13187(Fer4_9) | 6 | GLY A 297GLY A 70GLY A 386GLY A 381VAL A 28ILE A 235 | PDT A 4 (-3.3A)SF4 A 2 (-3.8A)SF4 A 3 ( 4.3A)SF4 A 3 ( 3.9A)SF4 A 2 (-4.7A)None | 1.14A | 3p97C-1e08A:undetectable | 3p97C-1e08A:19.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1eiz | FTSJ (Escherichiacoli) |
PF01728(FtsJ) | 5 | GLY A 59GLY A 64TRP A 65ASP A 99ASP A 124 | SAM A 301 (-3.6A)SAM A 301 (-3.1A)SAM A 301 (-3.6A)SAM A 301 (-3.5A)SAM A 301 (-3.6A) | 0.40A | 3p97C-1eizA:14.5 | 3p97C-1eizA:23.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ekq | HYDROXYETHYLTHIAZOLEKINASE (Bacillussubtilis) |
PF02110(HK) | 6 | GLY A 197GLY A 67GLY A 195THR A 68ASP A 94ILE A 66 | None | 1.40A | 3p97C-1ekqA:2.4 | 3p97C-1ekqA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1elt | ELASTASE (Salmo salar) |
PF00089(Trypsin) | 6 | GLY A 142GLY A 44GLY A 197GLY A 193VAL A 52ILE A 31 | None | 1.29A | 3p97C-1eltA:undetectable | 3p97C-1eltA:19.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ffv | CUTS, IRON-SULFURPROTEIN OF CARBONMONOXIDEDEHYDROGENASECUTL, MOLYBDOPROTEINOF CARBON MONOXIDEDEHYDROGENASE (Hydrogenophagapseudoflava;Hydrogenophagapseudoflava) |
PF00111(Fer2)PF01799(Fer2_2)PF01315(Ald_Xan_dh_C)PF02738(Ald_Xan_dh_C2) | 5 | GLY A 98GLY B 695GLY A 140THR B 698ILE B 693 | NoneARO B 384 ( 3.9A)NoneNoneNone | 0.89A | 3p97C-1ffvA:undetectable | 3p97C-1ffvA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kpl | PUTATIVE CLC FAMILY,CHLORINE TRANSPORTPROTEIN (Salmonellaenterica) |
PF00654(Voltage_CLC) | 5 | GLY A 196GLY A 408GLU A 203VAL A 222ILE A 197 | None | 0.85A | 3p97C-1kplA:undetectable | 3p97C-1kplA:20.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1l2q | MONOMETHYLAMINEMETHYLTRANSFERASE (Methanosarcinabarkeri) |
PF05369(MtmB) | 5 | GLY A 387GLY A 129GLY A 366THR A 131ILE A 156 | NoneNoneNoneXPL A 202 ( 4.5A)None | 0.75A | 3p97C-1l2qA:undetectable | 3p97C-1l2qA:22.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1muu | GDP-MANNOSE6-DEHYDROGENASE (Pseudomonasaeruginosa) |
PF00984(UDPG_MGDP_dh)PF03720(UDPG_MGDP_dh_C)PF03721(UDPG_MGDP_dh_N) | 5 | GLY A 147GLY A 153GLY A 151GLU A 178VAL A 125 | None | 0.86A | 3p97C-1muuA:3.1 | 3p97C-1muuA:21.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1mza | PRO-GRANZYME K (Homo sapiens) |
PF00089(Trypsin) | 5 | GLY A 44GLY A 142GLY A 193GLY A 196ASP A 145 | None | 0.87A | 3p97C-1mzaA:undetectable | 3p97C-1mzaA:21.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1op2 | VENOM SERINEPROTEINASE (Deinagkistrodonacutus) |
PF00089(Trypsin) | 6 | GLY A 142GLY A 44GLY A 196GLY A 193THR A 54VAL A 52 | None | 1.29A | 3p97C-1op2A:undetectable | 3p97C-1op2A:18.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1r66 | TDP-GLUCOSE-4,6-DEHYDRATASE (Streptomycesvenezuelae) |
PF16363(GDP_Man_Dehyd) | 6 | GLY A 244GLY A 226GLY A 243GLU A 289ASP A 27ASP A 222 | None | 1.37A | 3p97C-1r66A:5.3 | 3p97C-1r66A:24.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1r6a | GENOME POLYPROTEIN (Dengue virus) |
PF01728(FtsJ) | 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A 887 (-3.0A)SAH A 887 (-3.6A)SAH A 887 (-3.6A)SAH A 887 (-3.3A)SAH A 887 (-3.5A)SAH A 887 (-4.5A)SO4 A 902 (-2.7A)NoneSAH A 887 ( 3.3A)SAH A 887 (-3.5A)SAH A 887 (-3.9A)SAH A 887 ( 4.2A) | 0.55A | 3p97C-1r6aA:41.8 | 3p97C-1r6aA:75.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vcw | PROTEASE DEGS (Escherichiacoli) |
PF13180(PDZ_2)PF13365(Trypsin_2) | 5 | GLY A 214GLY A 82GLY A 202VAL A 106ILE A 91 | None | 0.87A | 3p97C-1vcwA:undetectable | 3p97C-1vcwA:20.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b25 | HYPOTHETICAL PROTEIN (Homo sapiens) |
PF08704(GCD14) | 5 | GLY A 111GLY A 113GLY A 116ASP A 173ASP A 192 | SAM A 601 (-2.9A)SAM A 601 (-3.2A)SAM A 601 (-3.5A)SAM A 601 (-3.4A)SAM A 601 (-3.5A) | 0.66A | 3p97C-2b25A:8.3 | 3p97C-2b25A:23.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dup | VESICULARINTEGRAL-MEMBRANEPROTEIN VIP36 (Canis lupus) |
PF03388(Lectin_leg-like) | 6 | GLY A 132GLY A 258GLU A 98ASP A 267VAL A 120ILE A 133 | None | 1.49A | 3p97C-2dupA:undetectable | 3p97C-2dupA:21.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2nyu | PUTATIVE RIBOSOMALRNAMETHYLTRANSFERASE 2 (Homo sapiens) |
PF01728(FtsJ) | 5 | GLY A 30TRP A 36ASP A 79VAL A 80ASP A 104 | SAM A 201 (-3.5A)SAM A 201 (-3.9A)SAM A 201 (-3.3A)SAM A 201 (-3.9A)SAM A 201 (-3.7A) | 0.49A | 3p97C-2nyuA:14.0 | 3p97C-2nyuA:21.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2nzo | PROTEIN CSAA (Bacillussubtilis) |
PF01588(tRNA_bind) | 6 | GLY A 15GLY A 106THR A 14VAL A 64ASP A 36ILE A 35 | None | 1.14A | 3p97C-2nzoA:undetectable | 3p97C-2nzoA:16.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2okj | GLUTAMATEDECARBOXYLASE 1 (Homo sapiens) |
PF00282(Pyridoxal_deC) | 5 | GLY A 351GLY A 379GLY A 346TRP A 376ILE A 480 | None | 0.87A | 3p97C-2okjA:undetectable | 3p97C-2okjA:19.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oxt | NUCLEOSIDE-2'-O-METHYLTRANSFERASE (Meaban virus) |
PF01728(FtsJ) | 9 | GLY A 59GLY A 82GLY A 84GLY A 87TRP A 88THR A 105GLU A 112ASP A 132ASP A 147 | SAM A 300 (-3.1A)SAM A 300 (-3.3A)SAM A 300 (-3.5A)SAM A 300 (-3.2A)SAM A 300 (-3.8A)SAM A 300 (-4.6A)NoneSAM A 300 (-3.9A)SAM A 300 (-3.9A) | 0.51A | 3p97C-2oxtA:39.7 | 3p97C-2oxtA:50.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oxt | NUCLEOSIDE-2'-O-METHYLTRANSFERASE (Meaban virus) |
PF01728(FtsJ) | 6 | GLY A 82GLY A 59GLY A 87GLY A 84THR A 60ASP A 147 | SAM A 300 (-3.3A)SAM A 300 (-3.1A)SAM A 300 (-3.2A)SAM A 300 (-3.5A)NoneSAM A 300 (-3.9A) | 1.36A | 3p97C-2oxtA:39.7 | 3p97C-2oxtA:50.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oy0 | METHYLTRANSFERASE (West Nile virus) |
PF01728(FtsJ) | 10 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A 301 (-3.4A)SAH A 301 (-3.0A)SAH A 301 (-3.2A)SAH A 301 (-3.0A)SAH A 301 (-3.7A)SAH A 301 (-4.4A)SAH A 301 (-3.2A)SAH A 301 (-3.8A)SAH A 301 (-4.2A)SAH A 301 ( 4.3A) | 0.51A | 3p97C-2oy0A:40.3 | 3p97C-2oy0A:60.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oy0 | METHYLTRANSFERASE (West Nile virus) |
PF01728(FtsJ) | 9 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 131VAL A 132 | SAH A 301 (-3.4A)SAH A 301 (-3.0A)SAH A 301 (-3.2A)SAH A 301 (-3.0A)SAH A 301 (-3.7A)SAH A 301 (-4.4A)NoneSAH A 301 (-3.2A)SAH A 301 (-3.8A) | 0.80A | 3p97C-2oy0A:40.3 | 3p97C-2oy0A:60.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oy0 | METHYLTRANSFERASE (West Nile virus) |
PF01728(FtsJ) | 6 | GLY A 58GLY A 83GLY A 86THR A 104LYS A 105GLU A 111 | SAH A 301 (-3.4A)SAH A 301 (-3.2A)SAH A 301 (-3.0A)SAH A 301 (-4.4A)NoneSAH A 301 (-3.5A) | 1.24A | 3p97C-2oy0A:40.3 | 3p97C-2oy0A:60.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2oy0 | METHYLTRANSFERASE (West Nile virus) |
PF01728(FtsJ) | 6 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SAH A 301 (-3.0A)SAH A 301 (-3.4A)SAH A 301 (-3.0A)SAH A 301 (-3.2A)NoneSAH A 301 (-4.2A) | 1.40A | 3p97C-2oy0A:40.3 | 3p97C-2oy0A:60.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2px5 | GENOME POLYPROTEIN[CONTAINS: CAPSIDPROTEIN C (COREPROTEIN) ENVELOPE PROTEIN M(MATRIX PROTEIN) MAJOR ENVELOPEPROTEIN E NON-STRUCTURALPROTEIN 1 (NS1) NON-STRUCTURALPROTEIN 2A (NS2A) FLAVIVIRIN PROTEASENS2B REGULATORYSUBUNIT FLAVIVIRIN PROTEASENS3 CATALYTICSUBUNIT NON-STRUCTURALPROTEIN 4A (NS4A) NON-STRUCTURALPROTEIN 4B (NS4B) RNA-DIRECTED RNAPOLYMERASE (EC2.7.7.48) (NS5)] (Murray Valleyencephalitisvirus) |
PF01728(FtsJ) | 10 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 (-3.5A)SAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A) | 0.39A | 3p97C-2px5A:41.2 | 3p97C-2px5A:60.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2px5 | GENOME POLYPROTEIN[CONTAINS: CAPSIDPROTEIN C (COREPROTEIN) ENVELOPE PROTEIN M(MATRIX PROTEIN) MAJOR ENVELOPEPROTEIN E NON-STRUCTURALPROTEIN 1 (NS1) NON-STRUCTURALPROTEIN 2A (NS2A) FLAVIVIRIN PROTEASENS2B REGULATORYSUBUNIT FLAVIVIRIN PROTEASENS3 CATALYTICSUBUNIT NON-STRUCTURALPROTEIN 4A (NS4A) NON-STRUCTURALPROTEIN 4B (NS4B) RNA-DIRECTED RNAPOLYMERASE (EC2.7.7.48) (NS5)] (Murray Valleyencephalitisvirus) |
PF01728(FtsJ) | 10 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105VAL A 132ASP A 146ILE A 147 | SAH A 500 (-3.3A)SAH A 500 (-3.4A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)NoneSAH A 500 (-3.6A)SAH A 500 (-3.6A)SAH A 500 ( 4.3A) | 0.67A | 3p97C-2px5A:41.2 | 3p97C-2px5A:60.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2px5 | GENOME POLYPROTEIN[CONTAINS: CAPSIDPROTEIN C (COREPROTEIN) ENVELOPE PROTEIN M(MATRIX PROTEIN) MAJOR ENVELOPEPROTEIN E NON-STRUCTURALPROTEIN 1 (NS1) NON-STRUCTURALPROTEIN 2A (NS2A) FLAVIVIRIN PROTEASENS2B REGULATORYSUBUNIT FLAVIVIRIN PROTEASENS3 CATALYTICSUBUNIT NON-STRUCTURALPROTEIN 4A (NS4A) NON-STRUCTURALPROTEIN 4B (NS4B) RNA-DIRECTED RNAPOLYMERASE (EC2.7.7.48) (NS5)] (Murray Valleyencephalitisvirus) |
PF01728(FtsJ) | 6 | GLY A 58GLY A 83GLY A 86TRP A 87THR A 104GLU A 111 | SAH A 500 (-3.3A)SAH A 500 ( 3.7A)SAH A 500 (-3.2A)SAH A 500 (-3.4A)SAH A 500 ( 4.6A)SAH A 500 ( 3.2A) | 0.94A | 3p97C-2px5A:41.2 | 3p97C-2px5A:60.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3u | PROTEASE DEGS (Escherichiacoli) |
PF13365(Trypsin_2) | 5 | GLY A 214GLY A 82GLY A 202VAL A 106ILE A 91 | None | 0.85A | 3p97C-2r3uA:undetectable | 3p97C-2r3uA:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r9h | H(+)/CL(-) EXCHANGETRANSPORTER CLCA (Escherichiacoli) |
PF00654(Voltage_CLC) | 5 | GLY A 196GLY A 408GLU A 203VAL A 222ILE A 197 | None | 0.89A | 3p97C-2r9hA:undetectable | 3p97C-2r9hA:20.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2wa2 | NON-STRUCTURALPROTEIN 5 (Modoc virus) |
PF01728(FtsJ) | 10 | GLY A 59GLY A 82GLY A 84TRP A 88THR A 105GLU A 112ASP A 132VAL A 133ASP A 147ILE A 148 | SAM A1248 ( 3.7A)SAM A1248 (-3.3A)SAM A1248 (-3.4A)SAM A1248 (-3.7A)SAM A1248 (-4.5A)NoneSAM A1248 (-3.6A)SAM A1248 (-3.4A)SAM A1248 (-3.7A)SAM A1248 ( 4.0A) | 0.38A | 3p97C-2wa2A:33.4 | 3p97C-2wa2A:49.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xn8 | PUTATIVE CYTOCHROMEP450 125 (Mycobacteriumtuberculosis) |
PF00067(p450) | 5 | GLY A 56GLY A 60GLY A 62GLY A 69ASP A 58 | None | 0.74A | 3p97C-2xn8A:undetectable | 3p97C-2xn8A:22.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xyq | PUTATIVE 2'-O-METHYLTRANSFERASE (Severe acuterespiratorysyndrome-relatedcoronavirus) |
PF06460(NSP13) | 5 | GLY A 71GLY A 73GLY A 81ASP A 114ASP A 130 | SAH A1293 (-3.8A)SAH A1293 (-4.1A)SAH A1293 (-3.6A)SAH A1293 (-3.7A)SAH A1293 (-3.7A) | 0.87A | 3p97C-2xyqA:10.5 | 3p97C-2xyqA:19.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2z8z | LIPASE (Pseudomonas sp.MIS38) |
PF00353(HemolysinCabind) | 5 | GLY A 505GLY A 520GLY A 523ASP A 534ASP A 507 | None CA A 626 ( 4.6A) CA A 624 ( 3.3A) CA A 625 ( 2.4A)None | 0.86A | 3p97C-2z8zA:undetectable | 3p97C-2z8zA:18.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3dou | RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE J (Thermoplasmavolcanium) |
PF01728(FtsJ) | 5 | GLY A 46GLY A 51TRP A 52ASP A 83ASP A 111 | SAM A 1 (-3.5A)SAM A 1 (-3.2A)SAM A 1 (-4.0A)SAM A 1 (-3.6A)SAM A 1 (-3.7A) | 0.48A | 3p97C-3douA:13.7 | 3p97C-3douA:19.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3elu | METHYLTRANSFERASE (Wesselsbronvirus) |
PF00972(Flavi_NS5)PF01728(FtsJ) | 10 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111VAL A 132ASP A 146ILE A 147 | SAM A4633 ( 3.7A)SAM A4633 (-3.2A)SAM A4633 (-3.4A)SAM A4633 (-3.4A)SAM A4633 (-3.5A)SAM A4633 (-4.5A)NoneSAM A4633 (-3.4A)SAM A4633 (-3.7A)SAM A4633 ( 4.2A) | 0.42A | 3p97C-3eluA:38.9 | 3p97C-3eluA:54.04 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3evc | RNA-DIRECTED RNAPOLYMERASE NS5 (Yellow fevervirus) |
PF01728(FtsJ) | 9 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131ASP A 146ILE A 147 | SAH A 901 (-3.2A)SAH A 901 (-3.4A)SAH A 901 (-3.3A)SAH A 901 (-3.1A)SAH A 901 (-3.6A)SAH A 901 (-4.5A)SAH A 901 (-3.7A)SAH A 901 (-3.8A)SAH A 901 ( 4.2A) | 0.22A | 3p97C-3evcA:40.7 | 3p97C-3evcA:54.01 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3evc | RNA-DIRECTED RNAPOLYMERASE NS5 (Yellow fevervirus) |
PF01728(FtsJ) | 6 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SAH A 901 (-3.4A)SAH A 901 (-3.2A)SAH A 901 (-3.1A)SAH A 901 (-3.3A)NoneSAH A 901 (-3.8A) | 1.32A | 3p97C-3evcA:40.7 | 3p97C-3evcA:54.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g01 | GRANZYME C (Mus musculus) |
PF00089(Trypsin) | 5 | GLY A 149GLY A 52GLY A 206GLY A 202VAL A 60 | None | 0.83A | 3p97C-3g01A:undetectable | 3p97C-3g01A:21.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g0i | EPOXIDE HYDROLASE (Aspergillusniger) |
PF06441(EHN) | 5 | GLY A 52GLY A 278GLY A 55VAL A 298ILE A 294 | None | 0.90A | 3p97C-3g0iA:undetectable | 3p97C-3g0iA:22.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3g48 | CHAPERONE CSAA (Bacillusanthracis) |
PF01588(tRNA_bind) | 5 | GLY A 15GLY A 105GLU A 39ASP A 36ILE A 35 | None | 0.80A | 3p97C-3g48A:undetectable | 3p97C-3g48A:18.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3gcz | POLYPROTEIN (Yokose virus) |
PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147 | SAM A4633 (-3.5A)SAM A4633 (-3.4A)SAM A4633 (-3.4A)SAM A4633 (-3.2A)SAM A4633 (-3.6A)SAM A4633 (-4.5A)NoneSAM A4633 (-3.7A)SAM A4633 (-3.6A)SAM A4633 (-3.7A)SAM A4633 ( 4.2A) | 0.37A | 3p97C-3gczA:40.9 | 3p97C-3gczA:55.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h41 | NLP/P60 FAMILYPROTEIN (Bacillus cereus) |
PF00877(NLPC_P60) | 5 | GLY A 235GLY A 218GLY A 233THR A 217ILE A 302 | None | 0.90A | 3p97C-3h41A:undetectable | 3p97C-3h41A:22.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h7t | GROUP 3 ALLERGENSMIPP-S YVT004A06 (Sarcoptesscabiei) |
PF00089(Trypsin) | 6 | GLY A 126GLY A 28GLY A 187GLY A 184THR A 38VAL A 36 | None | 1.30A | 3p97C-3h7tA:undetectable | 3p97C-3h7tA:19.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lgi | PROTEASE DEGS (Escherichiacoli) |
PF13365(Trypsin_2) | 5 | GLY A 214GLY A 82GLY A 202VAL A 106ILE A 91 | None | 0.79A | 3p97C-3lgiA:undetectable | 3p97C-3lgiA:23.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lkz | NON-STRUCTURALPROTEIN 5 (West Nile virus) |
PF01728(FtsJ) | 10 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.49A | 3p97C-3lkzA:40.9 | 3p97C-3lkzA:60.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lkz | NON-STRUCTURALPROTEIN 5 (West Nile virus) |
PF01728(FtsJ) | 9 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 131VAL A 132 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.1A)SFG A 301 (-4.1A) | 0.84A | 3p97C-3lkzA:40.9 | 3p97C-3lkzA:60.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lkz | NON-STRUCTURALPROTEIN 5 (West Nile virus) |
PF01728(FtsJ) | 8 | GLY A 58GLY A 83GLY A 86TRP A 87THR A 104LYS A 105GLU A 111VAL A 132 | SFG A 301 (-2.9A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.7A)SFG A 301 (-4.1A) | 1.15A | 3p97C-3lkzA:40.9 | 3p97C-3lkzA:60.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lkz | NON-STRUCTURALPROTEIN 5 (West Nile virus) |
PF01728(FtsJ) | 6 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.38A | 3p97C-3lkzA:40.9 | 3p97C-3lkzA:60.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nlc | UNCHARACTERIZEDPROTEIN VP0956 (Vibrioparahaemolyticus) |
no annotation | 6 | GLY A 104GLY A 162GLY A 159THR A 163GLU A 158ILE A 514 | FAD A 601 (-3.1A)FAD A 601 (-3.1A)NoneNoneNoneFAD A 601 (-3.9A) | 1.23A | 3p97C-3nlcA:undetectable | 3p97C-3nlcA:19.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nlc | UNCHARACTERIZEDPROTEIN VP0956 (Vibrioparahaemolyticus) |
no annotation | 5 | GLY A 264GLY A 162GLY A 160THR A 163ILE A 514 | FAD A 601 (-3.2A)FAD A 601 (-3.1A)FAD A 601 (-3.4A)NoneFAD A 601 (-3.9A) | 0.88A | 3p97C-3nlcA:undetectable | 3p97C-3nlcA:19.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3opy | 6-PHOSPHOFRUCTO-1-KINASE BETA-SUBUNIT (Komagataellapastoris) |
PF00365(PFK) | 5 | GLY B 383GLY B 433GLY B 380GLU B 432ILE B 442 | None | 0.84A | 3p97C-3opyB:undetectable | 3p97C-3opyB:14.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3r1i | SHORT-CHAIN TYPEDEHYDROGENASE/REDUCTASE (Mycobacteriummarinum) |
PF13561(adh_short_C2) | 6 | GLY A 22GLY A 97GLY A 18GLY A 24ASP A 117ILE A 98 | None | 1.34A | 3p97C-3r1iA:5.4 | 3p97C-3r1iA:23.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3r24 | 2'-O-METHYLTRANSFERASE (Severe acuterespiratorysyndrome-relatedcoronavirus) |
PF06460(NSP13) | 5 | GLY A 71GLY A 73GLY A 81ASP A 114ASP A 130 | SAM A 302 (-3.7A)SAM A 302 (-4.1A)SAM A 302 (-3.4A)SAM A 302 (-3.4A)SAM A 302 (-3.6A) | 0.87A | 3p97C-3r24A:10.5 | 3p97C-3r24A:20.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3s69 | THROMBIN-LIKE ENZYMEDEFIBRASE (Gloydiussaxatilis) |
PF00089(Trypsin) | 6 | GLY A 139GLY A 43GLY A 196GLY A 193THR A 53VAL A 51 | None | 1.28A | 3p97C-3s69A:undetectable | 3p97C-3s69A:20.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3s9b | VIPERA RUSSELLIPROTEINASE RVV-VGAMMA (Daboiasiamensis) |
PF00089(Trypsin) | 6 | GLY A 142GLY A 44GLY A 196GLY A 193THR A 54VAL A 52 | None | 1.25A | 3p97C-3s9bA:undetectable | 3p97C-3s9bA:20.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tvi | ASPARTOKINASE (Clostridiumacetobutylicum) |
PF00696(AA_kinase)PF01842(ACT) | 5 | GLY A 191GLY A 185GLU A 116VAL A 5ILE A 194 | NoneNoneASP A 451 (-3.9A)NoneNone | 0.88A | 3p97C-3tviA:undetectable | 3p97C-3tviA:22.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vyw | MNMC2 (Aquifexaeolicus) |
PF05430(Methyltransf_30) | 5 | GLY A 104GLY A 106LYS A 134ASP A 174ASP A 193 | SAM A 501 (-3.6A)SAM A 501 (-3.3A)SAM A 501 (-4.4A)SAM A 501 (-3.4A)SAM A 501 (-3.8A) | 0.82A | 3p97C-3vywA:4.7 | 3p97C-3vywA:24.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w9h | ACRIFLAVINERESISTANCE PROTEIN B (Escherichiacoli) |
PF00873(ACR_tran) | 5 | GLY A 290GLY A 288GLY A 179ASP A 328ILE A 291 | None | 0.87A | 3p97C-3w9hA:undetectable | 3p97C-3w9hA:13.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zk4 | DIPHOSPHONUCLEOTIDEPHOSPHATASE 1 (Lupinus luteus) |
PF00149(Metallophos)PF14008(Metallophos_C)PF16656(Pur_ac_phosph_N) | 6 | GLY A 274GLY A 476GLY A 271GLY A 516VAL A 437ASP A 313 | NoneNoneNoneNoneNone MN A 801 (-2.6A) | 1.43A | 3p97C-3zk4A:undetectable | 3p97C-3zk4A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zlb | PHOSPHOGLYCERATEKINASE (Streptococcuspneumoniae) |
PF00162(PGK) | 6 | GLY A 296GLY A 334GLY A 324THR A 335ASP A 340ILE A 304 | ANP A1401 (-4.2A)NoneANP A1401 (-3.3A)NoneNoneNone | 1.45A | 3p97C-3zlbA:undetectable | 3p97C-3zlbA:21.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4a9w | MONOOXYGENASE (Stenotrophomonasmaltophilia) |
PF13738(Pyr_redox_3) | 5 | GLY A 11GLY A 321GLY A 129GLY A 10ASP A 324 | FAD A1353 ( 4.7A)FAD A1353 ( 4.5A)FAD A1353 (-3.6A)FAD A1353 (-3.0A)SO4 A1359 (-3.6A) | 0.87A | 3p97C-4a9wA:undetectable | 3p97C-4a9wA:20.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4cjx | C-1-TETRAHYDROFOLATESYNTHASE,CYTOPLASMIC,PUTATIVE (Trypanosomabrucei) |
PF00763(THF_DHG_CYH)PF02882(THF_DHG_CYH_C) | 5 | GLY A 172GLY A 237GLY A 217GLY A 170VAL A 271 | NAP A1301 (-3.3A)NAP A1301 (-3.3A)NAP A1301 (-2.8A)NAP A1301 (-3.3A)None | 0.80A | 3p97C-4cjxA:undetectable | 3p97C-4cjxA:23.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dk1 | PUTATIVE MACA,MULTIDRUG RESISTANCEPROTEIN MEXA (Pseudomonasaeruginosa;Aggregatibacteractinomycetemcomitans) |
PF16576(HlyD_D23) | 5 | GLY A 261GLY A 50GLU A 196VAL A 211ILE A 249 | None | 0.74A | 3p97C-4dk1A:undetectable | 3p97C-4dk1A:22.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4e7n | SNAKE-VENOMTHROMBIN-LIKE ENZYME (Gloydius halys) |
PF00089(Trypsin) | 6 | GLY A 142GLY A 44GLY A 196GLY A 193THR A 54VAL A 52 | None | 1.25A | 3p97C-4e7nA:undetectable | 3p97C-4e7nA:18.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gc5 | DIMETHYLADENOSINETRANSFERASE 1,MITOCHONDRIAL (Mus musculus) |
PF00398(RrnaAD) | 6 | GLY A 63GLY A 65GLY A 68LYS A 86ASP A 111VAL A 112 | ACT A 402 (-3.4A)NoneNoneNoneNoneNone | 0.67A | 3p97C-4gc5A:8.5 | 3p97C-4gc5A:21.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hzu | ENERGY-COUPLINGFACTOR TRANSPORTERATP-BINDING PROTEINECFA 2 (Lactobacillusbrevis) |
PF00005(ABC_tran) | 6 | GLY A 216THR A 24ASP A 9VAL A 26ASP A 214ILE A 213 | None | 1.47A | 3p97C-4hzuA:undetectable | 3p97C-4hzuA:21.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4igl | YENB (Yersiniaentomophaga) |
PF03534(SpvB)PF12255(TcdB_toxin_midC)PF12256(TcdB_toxin_midN) | 5 | GLY A 626GLY A 628VAL A 587ASP A 631ILE A 632 | NoneNoneNone K A1503 (-2.5A)None | 0.86A | 3p97C-4iglA:undetectable | 3p97C-4iglA:10.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4k6m | POLYPROTEIN (Japaneseencephalitisvirus) |
PF00972(Flavi_NS5)PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A1001 (-3.1A)SAH A1001 (-3.3A)SAH A1001 ( 3.7A)SAH A1001 (-3.2A)SAH A1001 (-3.9A)SAH A1001 (-4.7A)SO4 A1011 (-4.9A)SAH A1001 (-3.7A)SAH A1001 (-3.7A)SAH A1001 (-3.6A)SAH A1001 ( 4.3A) | 0.49A | 3p97C-4k6mA:40.9 | 3p97C-4k6mA:61.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4k6m | POLYPROTEIN (Japaneseencephalitisvirus) |
PF00972(Flavi_NS5)PF01728(FtsJ) | 8 | GLY A 81GLY A 83GLY A 86THR A 104LYS A 105GLU A 111ASP A 131VAL A 132 | SAH A1001 (-3.3A)SAH A1001 ( 3.7A)SAH A1001 (-3.2A)SAH A1001 (-4.7A)NoneSO4 A1011 (-4.9A)SAH A1001 (-3.7A)SAH A1001 (-3.7A) | 1.19A | 3p97C-4k6mA:40.9 | 3p97C-4k6mA:61.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4k6m | POLYPROTEIN (Japaneseencephalitisvirus) |
PF00972(Flavi_NS5)PF01728(FtsJ) | 6 | GLY A 81GLY A 85TRP A 87GLU A 111ASP A 146ILE A 147 | SAH A1001 (-3.3A)SAH A1001 (-4.3A)SAH A1001 (-3.9A)SO4 A1011 (-4.9A)SAH A1001 (-3.6A)SAH A1001 ( 4.3A) | 1.16A | 3p97C-4k6mA:40.9 | 3p97C-4k6mA:61.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4kru | AUTOLYTIC LYSOZYME (Clostridiumphage phiSM101) |
PF01183(Glyco_hydro_25) | 6 | GLY A 11TRP A 155ASP A 29VAL A 31ASP A 13ILE A 12 | NoneNoneNoneNoneNDG A 501 (-3.6A)None | 1.47A | 3p97C-4kruA:undetectable | 3p97C-4kruA:21.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4kv7 | PROBABLELEUCINE/ISOLEUCINE/VALINE-BINDINGPROTEIN (Rhodopirellulabaltica) |
PF13458(Peripla_BP_6) | 6 | GLY A 209GLY A 202THR A 175ASP A 180VAL A 179ILE A 213 | None | 1.48A | 3p97C-4kv7A:undetectable | 3p97C-4kv7A:21.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4lrs | ACETALDEHYDEDEHYDROGENASE (Thermomonosporacurvata) |
PF01118(Semialdhyde_dh)PF09290(AcetDehyd-dimer) | 6 | GLY B 181GLY B 35GLY B 32GLY B 179THR B 36ILE B 28 | PEG B 409 ( 3.5A)NoneNAD B 401 (-3.2A)NAD B 401 (-3.5A)NoneNone | 1.24A | 3p97C-4lrsB:3.9 | 3p97C-4lrsB:20.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4n49 | CAP-SPECIFIC MRNA(NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1 (Homo sapiens) |
PF01728(FtsJ) | 5 | GLY A 279GLY A 282THR A 301ASP A 335ASP A 364 | SAM A 601 (-3.5A)SAM A 601 (-3.1A)SAM A 601 (-4.1A)SAM A 601 (-3.6A)SAM A 601 (-3.6A) | 0.63A | 3p97C-4n49A:15.7 | 3p97C-4n49A:22.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ra6 | L-ASPARAGINASE (Pyrococcusfuriosus) |
no annotation | 5 | GLY B 288GLY B 231GLY B 235GLY B 267ILE B 229 | None | 0.89A | 3p97C-4ra6B:undetectable | 3p97C-4ra6B:20.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ru5 | TAILSPIKE GP27 (Pseudomonasphage phi297) |
no annotation | 6 | GLY A 491GLY A 519GLY A 470THR A 520VAL A 522ILE A 548 | None | 1.21A | 3p97C-4ru5A:undetectable | 3p97C-4ru5A:16.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4uzj | NOTUM (Drosophilamelanogaster) |
PF03283(PAE) | 5 | GLY A 242GLY A 271GLY A 239ASP A 345VAL A 344 | None | 0.89A | 3p97C-4uzjA:undetectable | 3p97C-4uzjA:21.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ynn | PROTEASE DO (Legionellapneumophila) |
PF13180(PDZ_2)PF13365(Trypsin_2) | 5 | GLY A 203GLY A 66GLY A 191VAL A 91ILE A 76 | None | 0.82A | 3p97C-4ynnA:undetectable | 3p97C-4ynnA:20.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5a22 | VESICULAR STOMATITISVIRUS L POLYMERASE (Vesicularstomatitisvirus) |
PF00946(Mononeg_RNA_pol)PF14314(Methyltrans_Mon)PF14318(Mononeg_mRNAcap) | 5 | GLY A1670GLY A1672GLY A1675ASP A1735ASP A1762 | None | 0.72A | 3p97C-5a22A:12.2 | 3p97C-5a22A:9.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5aa5 | NIFE-HYDROGENASESMALL SUBUNIT, HOFKNIFE-HYDROGENASELARGE SUBUNIT, HOFG (Cupriavidusnecator;Cupriavidusnecator) |
PF01058(Oxidored_q6)PF14720(NiFe_hyd_SSU_C)PF00374(NiFeSe_Hases) | 6 | GLY A 29GLY A 34GLY A 97ASP C 86VAL C 205ASP A 33 | NoneSF4 A 503 ( 3.8A)SF4 A 503 ( 4.3A)NoneNoneNone | 1.42A | 3p97C-5aa5A:undetectable | 3p97C-5aa5A:21.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ccx | TRNA(ADENINE(58)-N(1))-METHYLTRANSFERASECATALYTIC SUBUNITTRMT61A (Homo sapiens) |
PF08704(GCD14) | 6 | GLY A 111GLY A 113ASP A 163VAL A 164ASP A 181ILE A 182 | SAH A 301 (-3.2A)SAH A 301 (-2.9A)SAH A 301 (-2.7A)SAH A 301 (-4.0A)SAH A 301 (-2.4A)SAH A 301 ( 3.8A) | 0.87A | 3p97C-5ccxA:9.2 | 3p97C-5ccxA:22.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ccx | TRNA(ADENINE(58)-N(1))-METHYLTRANSFERASECATALYTIC SUBUNITTRMT61A (Homo sapiens) |
PF08704(GCD14) | 6 | GLY A 111GLY A 115ASP A 163VAL A 164ASP A 181ILE A 182 | SAH A 301 (-3.2A)SAH A 301 (-3.9A)SAH A 301 (-2.7A)SAH A 301 (-4.0A)SAH A 301 (-2.4A)SAH A 301 ( 3.8A) | 0.96A | 3p97C-5ccxA:9.2 | 3p97C-5ccxA:22.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5e7q | ACYL-COA SYNTHETASE (Streptomycesplatensis) |
PF00501(AMP-binding)PF13193(AMP-binding_C) | 5 | GLY A 308GLY A 318GLY A 312GLY A 310ILE A 216 | SO4 A 709 ( 3.9A)NoneNoneNoneNone | 0.88A | 3p97C-5e7qA:undetectable | 3p97C-5e7qA:17.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5e9q | GENOME POLYPROTEIN (Dengue virus) |
PF01728(FtsJ) | 10 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131VAL A 132ASP A 146ILE A 147 | SAM A 301 (-3.2A)SAM A 301 (-3.3A)SAM A 301 (-3.1A)SAM A 301 (-3.1A)SAM A 301 (-3.6A)SAM A 301 (-4.6A)SAM A 301 (-3.4A)SAM A 301 (-3.6A)SAM A 301 (-3.8A)SAM A 301 ( 4.2A) | 0.27A | 3p97C-5e9qA:43.9 | 3p97C-5e9qA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5e9q | GENOME POLYPROTEIN (Dengue virus) |
PF01728(FtsJ) | 6 | GLY A 58GLY A 83GLY A 86THR A 104LYS A 105ASP A 131 | SAM A 301 (-3.2A)SAM A 301 (-3.1A)SAM A 301 (-3.1A)SAM A 301 (-4.6A)NoneSAM A 301 (-3.4A) | 0.95A | 3p97C-5e9qA:43.9 | 3p97C-5e9qA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gvt | PLASMA KALLIKREIN (Mus musculus) |
no annotation | 6 | GLY A 142GLY A 44GLY A 196GLY A 193THR A 54VAL A 52 | None | 1.26A | 3p97C-5gvtA:undetectable | 3p97C-5gvtA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hdm | GLUTAMATE-1-SEMIALDEHYDE 2,1-AMINOMUTASE1, CHLOROPLASTIC (Arabidopsisthaliana) |
PF00202(Aminotran_3) | 6 | GLY A 283GLY A 317GLY A 278GLY A 273THR A 320ILE A 318 | None | 1.44A | 3p97C-5hdmA:undetectable | 3p97C-5hdmA:21.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hxw | L-AMINO ACIDDEAMINASE (Proteusvulgaris) |
PF01266(DAO) | 5 | GLY A 66GLY A 257GLY A 61VAL A 271ILE A 420 | NoneFAD A 501 (-3.4A)FAD A 501 (-3.1A)NoneNone | 0.85A | 3p97C-5hxwA:undetectable | 3p97C-5hxwA:21.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5i39 | L-AMINO ACIDDEAMINASE (Proteusvulgaris) |
PF01266(DAO) | 5 | GLY A 66GLY A 257GLY A 61VAL A 271ILE A 420 | NoneFAD A 501 (-3.4A)FAD A 501 (-3.2A)NoneNone | 0.89A | 3p97C-5i39A:2.8 | 3p97C-5i39A:21.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ikm | NS5 METHYLTRANSFERASE (Dengue virus) |
PF01728(FtsJ) | 10 | GLY A 58GLY A 81GLY A 83GLY A 86THR A 104LYS A 105GLU A 111ASP A 131VAL A 132ILE A 147 | SAM A 311 (-3.3A)SAM A 311 (-3.2A)SAM A 311 (-3.3A)SAM A 311 (-3.3A)SAM A 311 (-4.5A)MLT A 313 ( 3.0A)NoneMLT A 313 ( 2.6A)SAM A 311 (-3.7A)SAM A 311 ( 4.3A) | 0.68A | 3p97C-5ikmA:42.5 | 3p97C-5ikmA:81.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ikm | NS5 METHYLTRANSFERASE (Dengue virus) |
PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 131VAL A 132ASP A 146ILE A 147 | SAM A 311 (-3.3A)SAM A 311 (-3.2A)SAM A 311 (-3.3A)SAM A 311 (-3.3A)SAM A 311 (-3.5A)SAM A 311 (-4.5A)MLT A 313 ( 3.0A)MLT A 313 ( 2.6A)SAM A 311 (-3.7A)SAM A 311 (-3.8A)SAM A 311 ( 4.3A) | 0.43A | 3p97C-5ikmA:42.5 | 3p97C-5ikmA:81.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ikm | NS5 METHYLTRANSFERASE (Dengue virus) |
PF01728(FtsJ) | 6 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SAM A 311 (-3.2A)SAM A 311 (-3.3A)SAM A 311 (-3.3A)SAM A 311 (-3.3A)NoneSAM A 311 (-3.8A) | 1.33A | 3p97C-5ikmA:42.5 | 3p97C-5ikmA:81.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jd8 | PERIPLASMIC SERINEPEPTIDASE DEGS (Yersinia pestis) |
PF13180(PDZ_2)PF13365(Trypsin_2) | 5 | GLY A 213GLY A 82GLY A 201VAL A 106ILE A 91 | None | 0.78A | 3p97C-5jd8A:undetectable | 3p97C-5jd8A:20.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5jjr | GENOME POLYPROTEIN (Dengue virus) |
PF00972(Flavi_NS5)PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A1003 (-3.2A)SAH A1003 (-3.4A)SAH A1003 (-3.5A)SAH A1003 (-3.0A)SAH A1003 (-3.4A)SAH A1003 (-4.6A)SAH A1003 (-4.8A)SAH A1003 (-3.0A)SAH A1003 (-3.7A)SAH A1003 (-3.8A)SAH A1003 ( 4.3A) | 0.47A | 3p97C-5jjrA:43.8 | 3p97C-5jjrA:99.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kpg | PAVINEN-METHYLTRANSFERASE (Thalictrumflavum) |
PF02353(CMAS) | 5 | GLY A 135GLY A 137THR A 158ASP A 185VAL A 186 | SAH A 401 (-3.7A)SAH A 401 ( 3.8A)NoneSAH A 401 (-3.5A)SAH A 401 (-3.8A) | 0.57A | 3p97C-5kpgA:7.5 | 3p97C-5kpgA:20.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nju | GENOME POLYPROTEIN (Zika virus) |
no annotation | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A1001 (-3.3A)SAH A1001 (-3.4A)SAH A1001 (-3.4A)SAH A1001 (-3.3A)SAH A1001 (-3.5A)SAH A1001 (-4.4A)NoneSAH A1001 (-3.9A)SAH A1001 (-3.6A)SAH A1001 (-3.7A)SAH A1001 (-4.2A) | 0.27A | 3p97C-5njuA:40.2 | 3p97C-5njuA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nju | GENOME POLYPROTEIN (Zika virus) |
no annotation | 8 | GLY A 81GLY A 83GLY A 86THR A 104LYS A 105GLU A 111ASP A 131VAL A 132 | SAH A1001 (-3.4A)SAH A1001 (-3.4A)SAH A1001 (-3.3A)SAH A1001 (-4.4A)NoneNoneSAH A1001 (-3.9A)SAH A1001 (-3.6A) | 1.11A | 3p97C-5njuA:40.2 | 3p97C-5njuA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5svc | ACETONE CARBOXYLASEALPHA SUBUNIT (Xanthobacterautotrophicus) |
PF02538(Hydantoinase_B) | 5 | GLY A 510GLY A 431GLY A 464GLY A 627ASP A 545 | None | 0.89A | 3p97C-5svcA:undetectable | 3p97C-5svcA:15.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tmh | POLYPROTEIN (Zika virus) |
PF00972(Flavi_NS5)PF01728(FtsJ) | 11 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147 | SAH A1001 (-3.2A)SAH A1001 (-3.4A)SAH A1001 ( 3.8A)SAH A1001 (-3.6A)SAH A1001 (-3.5A)SAH A1001 ( 4.9A)NoneSAH A1001 (-4.0A)SAH A1001 (-4.0A)SAH A1001 (-3.8A)SAH A1001 ( 4.8A) | 0.43A | 3p97C-5tmhA:40.2 | 3p97C-5tmhA:22.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5u4q | DTDP-GLUCOSE4,6-DEHYDRATASE (Klebsiellapneumoniae) |
PF16363(GDP_Man_Dehyd) | 5 | GLY A 183GLY A 13GLY A 186VAL A 5ILE A 16 | CL A 402 (-4.3A)None CL A 402 ( 4.4A)NoneNone | 0.80A | 3p97C-5u4qA:5.0 | 3p97C-5u4qA:20.17 |